Cynata Therapeutics Limited (ASX:CYP)
Australia · Delayed Price · Currency is AUD 0.0140
+0.0020 (16.67%)
Oct 9, 2026, 4:10 PM AEST
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 3.41 million as of October 9, 2026. It is the 47,540th most valuable company in the world and the 1,623rd biggest in Australia. Its market cap has decreased by 93.76% in one year.
Market Cap
3.41M
Enterprise Value
2.51M
Revenue
1.71M
Global Rank
Country Rank
#1,623 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has decreased from 15.60M to 3.41M, a decrease of -78.15%. That is a compound annual growth rate of -7.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.41M | -95.84% |
| Dec 31, 2025 | 81.92M | 51.54% |
| Dec 31, 2024 | 54.06M | 140.75% |
| Dec 29, 2023 | 22.45M | -47.76% |
| Dec 30, 2022 | 42.98M | -44.95% |
| Dec 31, 2021 | 78.09M | -17.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 11.24M |
| Invex Therapeutics | 8.27M |
| Bio-Gene Technology | 7.01M |
| Vectus Biosystems | 6.53M |
| Acrux | 6.49M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.57M |